Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy

Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy

Advanced prostate cancer remains incurable and is the second leading cause of mortality in men. Immunotherapy based on the adoptive transfer of tumor-infiltrating lymphocytes (TIL) has demonstrated promising clinical results in patients with metastatic melanoma and lately also in other solid tumors....

Full description

Bibliographic Details
Main Authors: Sharon Yunger, Assaf Bar El, Li-at Zeltzer, Eddie Fridman, Gil Raviv, Menachem Laufer, Jacob Schachter, Gal Markel, Orit Itzhaki, Michal J Besser
Format: Article
Language:English
Published: Taylor & Francis Group 2019-12-01
Series:OncoImmunology
Subjects:
adoptive cell therapy (act)
tumor infiltrating lymphocyte (til)
prostate cancer (pca)
immunotherapy
primary prostate cancer cultures
Online Access:http://dx.doi.org/10.1080/2162402X.2019.1672494

Internet

http://dx.doi.org/10.1080/2162402X.2019.1672494

Similar Items